As is known to all, lung cancer patients with EGFR mutation, pathologically low differentiation, advanced pathological stage, and high Ki-67 index have a worse prognosis (36–39), which also suggests the potential prognostic value of the 7-AAB panel test to some extent. The gene discussed is EGFR; the disease is lung carcinoma.